Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201


Sébastien Jeay
Nov 1, 2018; 78:6257-6267
Adjuvant Endocrine Therapy

Powered by WPeMatico

Leave a Reply